Kimberley A. Jackson
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study.
Journal: Clinical therapeutics
Published: June 11, 2024
Sociologists in public health: marginal observers or mainstream collaborators?
Journal: Perspectives in public health
Published: March 18, 2024
Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study.
Journal: Advances in therapy
Published: April 14, 2023
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS).
Journal: British journal of clinical pharmacology
Published: March 30, 2021
Developing an online patient education resource for topical therapy: a pilot study.
Journal: The British journal of dermatology
Published: August 18, 2019
Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque Psoriasis.
Journal: The Journal of investigative dermatology
Published: March 21, 2018
Exposure-Response Modeling to Characterize the Relationship Between Ixekizumab Serum Drug Concentrations and Efficacy Responses at Week 12 in Patients With Moderate to Severe Plaque Psoriasis.
Journal: Journal of clinical pharmacology
Published: February 23, 2018
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: November 09, 2017
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects.
Journal: Psychopharmacology
Published: September 07, 2017
Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
Journal: Neuropharmacology
Published: July 07, 2017
Bone density and body composition in newly licenced professional jockeys.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: October 17, 2016
Last Updated: 09/26/2026